US Stock MarketDetailed Quotes

Revelation Biosciences (REVB)

Watchlist
  • 0.8999
  • -0.0001-0.01%
Close Jan 15 16:00 ET
5.33MMarket Cap0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revelation Biosciences (REVB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
Net income from continuing operations
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
Operating gains losses
275.40%10.6K
99.03%-43
97.93%-1.42K
99.02%-81.44K
96.25%-2.56K
93.47%-6.04K
98.96%-4.42K
99.12%-68.43K
---8.33M
---68.2K
Depreciation and amortization
-6.30%6.77K
0.00%7.22K
15.31%7.22K
11.47%27.92K
15.31%7.22K
15.30%7.22K
15.30%7.22K
-0.02%6.26K
0.00%25.05K
0.00%6.26K
Other non cash items
----
--0
--6.72K
--25K
--0
--0
----
----
----
----
Change In working capital
104.35%306.76K
-91.16%517.05K
-674.37%-979.3K
-448.53%-3.42M
-1,013.02%-2.1M
-829.76%-7.05M
3,247.47%5.85M
-355.37%-126.47K
234.36%982.14K
3.80%229.91K
-Change in prepaid assets
686.56%62.12K
169.10%37.22K
-1,321.78%-156.57K
255.65%17.99K
-24.72%51.15K
-91.89%7.9K
-165.39%-53.87K
104.94%12.82K
-102.03%-11.56K
-71.27%67.95K
-Change in payables and accrued expense
103.47%244.65K
-91.87%479.83K
-291.01%-822.73K
-485.27%-3.51M
-1,624.50%-2.15M
-912.48%-7.06M
2,301.11%5.91M
-223.53%-210.41K
174.59%911.62K
205.61%141.05K
-Change in other working capital
----
----
----
-13.33%71.13K
--0
--0
--0
16.32%71.13K
234.20%82.07K
--20.92K
Cash from discontinued investing activities
Operating cash flow
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-19.17K
17.69K
-17.69K
0
-19.17K
0
0
Net PPE purchase and sale
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
---19.17K
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
---19.17K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
143.77%9.12M
3.39M
0
-8.39%12.85M
3.69M
3.74M
0
-61.37%5.42M
-7.72%14.03M
0
Net common stock issuance
--0
--3.39M
--0
-61.39%5.42M
--0
--0
--0
-61.39%5.42M
215.21%14.03M
--0
Net preferred stock issuance
----
----
----
--0
--0
--0
--0
--0
-200.00%-5K
--0
Proceeds from stock option exercised by employees
143.77%9.12M
--297
--0
21,854,932.35%7.43M
--3.69M
--3.74M
--0
568.42%127
-99.33%34
--0
Cash from discontinued financing activities
Financing cash flow
143.77%9.12M
--3.39M
--0
-8.39%12.85M
--3.69M
--3.74M
--0
-61.37%5.42M
-7.72%14.03M
--0
Net cash flow
Beginning cash position
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
128.28%11.99M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
312.09%5.25M
125.88%13.99M
Current changes in cash
236.20%7.53M
159.28%1.47M
-209.15%-2.79M
-181.51%-5.49M
97.90%-42.03K
-222.25%-5.53M
-24.46%-2.48M
-79.44%2.56M
69.39%6.74M
-112.51%-2M
End cash Position
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
-45.80%6.5M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
128.28%11.99M
Free cash flow
82.87%-1.59M
22.57%-1.92M
2.20%-2.79M
-151.71%-18.34M
-86.23%-3.73M
-440.27%-9.27M
-24.46%-2.48M
-81.39%-2.86M
35.06%-7.29M
-111.39%-2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M
Net income from continuing operations 14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M
Operating gains losses 275.40%10.6K99.03%-4397.93%-1.42K99.02%-81.44K96.25%-2.56K93.47%-6.04K98.96%-4.42K99.12%-68.43K---8.33M---68.2K
Depreciation and amortization -6.30%6.77K0.00%7.22K15.31%7.22K11.47%27.92K15.31%7.22K15.30%7.22K15.30%7.22K-0.02%6.26K0.00%25.05K0.00%6.26K
Other non cash items ------0--6.72K--25K--0--0----------------
Change In working capital 104.35%306.76K-91.16%517.05K-674.37%-979.3K-448.53%-3.42M-1,013.02%-2.1M-829.76%-7.05M3,247.47%5.85M-355.37%-126.47K234.36%982.14K3.80%229.91K
-Change in prepaid assets 686.56%62.12K169.10%37.22K-1,321.78%-156.57K255.65%17.99K-24.72%51.15K-91.89%7.9K-165.39%-53.87K104.94%12.82K-102.03%-11.56K-71.27%67.95K
-Change in payables and accrued expense 103.47%244.65K-91.87%479.83K-291.01%-822.73K-485.27%-3.51M-1,624.50%-2.15M-912.48%-7.06M2,301.11%5.91M-223.53%-210.41K174.59%911.62K205.61%141.05K
-Change in other working capital -------------13.33%71.13K--0--0--016.32%71.13K234.20%82.07K--20.92K
Cash from discontinued investing activities
Operating cash flow 82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M
Investing cash flow
Cash flow from continuing investing activities 000-19.17K17.69K-17.69K0-19.17K00
Net PPE purchase and sale --0--0--0---19.17K--17.69K---17.69K--0---19.17K--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0---19.17K--17.69K---17.69K--0---19.17K--0--0
Financing cash flow
Cash flow from continuing financing activities 143.77%9.12M3.39M0-8.39%12.85M3.69M3.74M0-61.37%5.42M-7.72%14.03M0
Net common stock issuance --0--3.39M--0-61.39%5.42M--0--0--0-61.39%5.42M215.21%14.03M--0
Net preferred stock issuance --------------0--0--0--0--0-200.00%-5K--0
Proceeds from stock option exercised by employees 143.77%9.12M--297--021,854,932.35%7.43M--3.69M--3.74M--0568.42%127-99.33%34--0
Cash from discontinued financing activities
Financing cash flow 143.77%9.12M--3.39M--0-8.39%12.85M--3.69M--3.74M--0-61.37%5.42M-7.72%14.03M--0
Net cash flow
Beginning cash position -57.15%5.17M-74.54%3.7M-45.80%6.5M128.28%11.99M-53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M312.09%5.25M125.88%13.99M
Current changes in cash 236.20%7.53M159.28%1.47M-209.15%-2.79M-181.51%-5.49M97.90%-42.03K-222.25%-5.53M-24.46%-2.48M-79.44%2.56M69.39%6.74M-112.51%-2M
End cash Position 94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M-45.80%6.5M-53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M128.28%11.99M
Free cash flow 82.87%-1.59M22.57%-1.92M2.20%-2.79M-151.71%-18.34M-86.23%-3.73M-440.27%-9.27M-24.46%-2.48M-81.39%-2.86M35.06%-7.29M-111.39%-2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -